Sodian R, Hoerstrup S P, Sperling J S, Daebritz S H, Martin D P, Schoen F J, Vacanti J P, Mayer J E
Department of Cardiac Research, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Ann Thorac Surg. 2000 Jul;70(1):140-4. doi: 10.1016/s0003-4975(00)01255-8.
Tissue engineering is a new approach, whereby techniques are being developed to transplant autologous cells onto biodegradable scaffolds to ultimately form new functional tissue in vitro and in vivo. Our laboratory has focused on the tissue engineering of heart valves, and we have fabricated a trileaflet heart valve scaffold from a biodegradable polymer, a polyhydroxyalkanoate. In this experiment we evaluated the suitability of this scaffold material as well as in vitro conditioning to create viable tissue for tissue engineering of a trileaflet heart valve.
We constructed a biodegradable and biocompatible trileaflet heart valve scaffold from a porous polyhydroxyalkanoate (Meatabolix Inc, Cambridge, MA). The scaffold consisted of a cylindrical stent (1 x 15 x 20 mm inner diameter) and leaflets (0.3 mm thick), which were attached to the stent by thermal processing techniques. The porous heart valve scaffold (pore size 100 to 240 microm) was seeded with vascular cells grown and expanded from an ovine carotid artery and placed into a pulsatile flow bioreactor for 1, 4, and 8 days. Analysis of the engineered tissue included biochemical examination, enviromental scanning electron microscopy, and histology.
It was possible to create a trileaflet heart valve scaffold from polyhydroxyalkanoate, which opened and closed synchronously in a pulsatile flow bioreactor. The cells grew into the pores and formed a confluent layer after incubation and pulsatile flow exposure. The cells were mostly viable and formed connective tissue between the inside and the outside of the porous heart valve scaffold. Additionally, we demonstrated cell proliferation (DNA assay) and the capacity to generate collagen as measured by hydroxyproline assay and movat-stained glycosaminoglycans under in vitro pulsatile flow conditions.
Polyhydroxyalkanoates can be used to fabricate a porous, biodegradable heart valve scaffold. The cells appear to be viable and extracellular matrix formation was induced after pulsatile flow exposure.
组织工程是一种新方法,目前正在开发相关技术,将自体细胞移植到可生物降解支架上,最终在体外和体内形成新的功能组织。我们实验室专注于心脏瓣膜的组织工程,并且我们已经用一种可生物降解聚合物——聚羟基脂肪酸酯制作了一个三叶心脏瓣膜支架。在本实验中,我们评估了这种支架材料的适用性以及体外预处理,以便为三叶心脏瓣膜的组织工程创建有活力的组织。
我们用一种多孔聚羟基脂肪酸酯(马萨诸塞州剑桥市的Megaabolix公司)构建了一个可生物降解且生物相容的三叶心脏瓣膜支架。该支架由一个圆柱形支架(内径1×15×20毫米)和瓣膜小叶(0.3毫米厚)组成,瓣膜小叶通过热处理技术附着在支架上。将从羊颈动脉中培养并扩增的血管细胞接种到多孔心脏瓣膜支架(孔径100至240微米)上,并置于搏动流生物反应器中1天、4天和8天。对工程组织的分析包括生化检查、环境扫描电子显微镜检查和组织学检查。
用聚羟基脂肪酸酯制作一个三叶心脏瓣膜支架是可行的,该支架在搏动流生物反应器中能同步开合。细胞在培养和搏动流暴露后长入孔隙并形成汇合层。细胞大多存活,并在多孔心脏瓣膜支架的内外形成结缔组织。此外,我们还证明了在体外搏动流条件下细胞增殖(DNA检测)以及通过羟脯氨酸检测和莫瓦特染色的糖胺聚糖测量生成胶原蛋白的能力。
聚羟基脂肪酸酯可用于制造多孔、可生物降解的心脏瓣膜支架。搏动流暴露后,细胞似乎具有活力并诱导了细胞外基质的形成。